John Poulos
Director/Board Member at FARON PHARMACEUTICALS OY
Net worth: 17 370 $ as of 31/03/2024
Profile
Mr. John Poulos is an Independent Non-Executive Director at Faron Pharmaceuticals Oy and a President at GNK Advisors, Inc. He is on the Board of Directors at Memgen, Inc. and Faron Pharmaceuticals Oy.
Mr. Poulos was previously employed as a VP, Head-Business Development & Acquisitions by AbbVie Oy and a Head-Pharmaceutical Licensing & Acquisitions by Abbott Pharmaceutical, Inc. He received his undergraduate degree from Indiana University and an MBA from Indiana University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
FARON PHARMACEUTICALS OY
0.01% | 27/10/2023 | 10,000 ( 0.01% ) | 17 370 $ | 31/03/2024 |
John Poulos active positions
| Companies | Position | Start |
|---|---|---|
| FARON PHARMACEUTICALS OY | Director/Board Member | 16/05/2017 |
Memgen, Inc.
 Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Director/Board Member | 18/11/2020 |
| GNK Advisors, Inc. | President | 01/01/2017 |
Former positions of John Poulos
| Companies | Position | End |
|---|---|---|
AbbVie Oy
 AbbVie Oy Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie Oy is a Finnish company that manufactures and wholesales pharmaceutical products. The private company is based in Espoo, Finland. | Corporate Officer/Principal | 01/01/2016 |
| Abbott Pharmaceutical, Inc. | Corporate Officer/Principal | 01/01/2012 |
Training of John Poulos
| Indiana University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| FARON PHARMACEUTICALS OY | Health Technology |
| Private companies | 4 |
|---|---|
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Health Technology |
| Abbott Pharmaceutical, Inc. | |
AbbVie Oy
AbbVie Oy Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie Oy is a Finnish company that manufactures and wholesales pharmaceutical products. The private company is based in Espoo, Finland. | Health Technology |
| GNK Advisors, Inc. |
- Stock Market
- Insiders
- John Poulos
